JP5929812B2 - １，２，４−トリアゾロン誘導体を含有する医薬 - Google Patents
１，２，４−トリアゾロン誘導体を含有する医薬 Download PDFInfo
- Publication number
- JP5929812B2 JP5929812B2 JP2013068344A JP2013068344A JP5929812B2 JP 5929812 B2 JP5929812 B2 JP 5929812B2 JP 2013068344 A JP2013068344 A JP 2013068344A JP 2013068344 A JP2013068344 A JP 2013068344A JP 5929812 B2 JP5929812 B2 JP 5929812B2
- Authority
- JP
- Japan
- Prior art keywords
- reference example
- oxo
- dihydro
- triazol
- acetamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCC(C)C1=CC*C1 Chemical compound CCC(C)C1=CC*C1 0.000 description 9
- FHNQBRVXINLPIN-QQTULTPQSA-N C=[Br]c(c(/C(/C(O)=O)=N/Nc1ccc(CCN2CCOCC2)cc1)c1)ccc1Cl Chemical compound C=[Br]c(c(/C(/C(O)=O)=N/Nc1ccc(CCN2CCOCC2)cc1)c1)ccc1Cl FHNQBRVXINLPIN-QQTULTPQSA-N 0.000 description 1
- NTXMPRADPAPRTD-UHFFFAOYSA-N CC(C)(C)NC(CN(C(c1cccc(Cl)c1)=NN1c(cc2)ncc2Br)C1=O)=O Chemical compound CC(C)(C)NC(CN(C(c1cccc(Cl)c1)=NN1c(cc2)ncc2Br)C1=O)=O NTXMPRADPAPRTD-UHFFFAOYSA-N 0.000 description 1
- KNDKEEMJLXNTHH-UHFFFAOYSA-N CC(C)(C)NC(CN(C(c1cccc(Cl)c1)=NN1c2ccc(CCN3CCOCC3)cc2)C1=O)=O Chemical compound CC(C)(C)NC(CN(C(c1cccc(Cl)c1)=NN1c2ccc(CCN3CCOCC3)cc2)C1=O)=O KNDKEEMJLXNTHH-UHFFFAOYSA-N 0.000 description 1
- HQVXNOUBRLJSEP-UHFFFAOYSA-N CC(C)(C)NC(CN(C(c1cccc(OC)c1)=NN1c2ncc(CCO)cc2)C1=O)=O Chemical compound CC(C)(C)NC(CN(C(c1cccc(OC)c1)=NN1c2ncc(CCO)cc2)C1=O)=O HQVXNOUBRLJSEP-UHFFFAOYSA-N 0.000 description 1
- RRGVYHRISRGKKR-NFFVHWSESA-N CC(C)NC(CN(C(C)=O)/C(/c(cc1)cc(Cl)c1F)=N\Nc1ccc(CCOC)cc1)=O Chemical compound CC(C)NC(CN(C(C)=O)/C(/c(cc1)cc(Cl)c1F)=N\Nc1ccc(CCOC)cc1)=O RRGVYHRISRGKKR-NFFVHWSESA-N 0.000 description 1
- HRFRXBMNIAJFOS-UHFFFAOYSA-N CC(C)NC(CN(C(c(cc1)cc(Cl)c1F)=NN1c(cc2)ncc2Br)C1=O)=O Chemical compound CC(C)NC(CN(C(c(cc1)cc(Cl)c1F)=NN1c(cc2)ncc2Br)C1=O)=O HRFRXBMNIAJFOS-UHFFFAOYSA-N 0.000 description 1
- PZZPKZLDIATNMO-UHFFFAOYSA-N CC(C)NC(CN(C(c1cccc(Cl)c1)=NN1c(cc2)cnc2Cl)C1=O)=O Chemical compound CC(C)NC(CN(C(c1cccc(Cl)c1)=NN1c(cc2)cnc2Cl)C1=O)=O PZZPKZLDIATNMO-UHFFFAOYSA-N 0.000 description 1
- XLZNHOSFCQVEPL-UHFFFAOYSA-N CC(Cc(cc1)ccc1Br)N1CCOCC1 Chemical compound CC(Cc(cc1)ccc1Br)N1CCOCC1 XLZNHOSFCQVEPL-UHFFFAOYSA-N 0.000 description 1
- OPNPEOPPYXTTHV-UHFFFAOYSA-N CCOC(CNC(NNC(c1cc(Cl)ccc1)=O)=O)=O Chemical compound CCOC(CNC(NNC(c1cc(Cl)ccc1)=O)=O)=O OPNPEOPPYXTTHV-UHFFFAOYSA-N 0.000 description 1
- BVUFKEDTAGUKMM-UHFFFAOYSA-N CCOC(CNC(NNC(c1cc(S(C)(=O)=O)ccc1)=O)=O)=O Chemical compound CCOC(CNC(NNC(c1cc(S(C)(=O)=O)ccc1)=O)=O)=O BVUFKEDTAGUKMM-UHFFFAOYSA-N 0.000 description 1
- QONFPSFEOUONOS-JXAWBTAJSA-N COc1cccc(/C(/C(O)=O)=N/Nc(cc2)ccc2Br)c1 Chemical compound COc1cccc(/C(/C(O)=O)=N/Nc(cc2)ccc2Br)c1 QONFPSFEOUONOS-JXAWBTAJSA-N 0.000 description 1
- ANSAIZCMEIQMRM-UHFFFAOYSA-M CS(c1cccc(C(Cl)=O)c1)([O-])=O Chemical compound CS(c1cccc(C(Cl)=O)c1)([O-])=O ANSAIZCMEIQMRM-UHFFFAOYSA-M 0.000 description 1
- IWCOWSOWLSLUDK-UHFFFAOYSA-N NNc1ccc(CCN2CCOCC2)cc1 Chemical compound NNc1ccc(CCN2CCOCC2)cc1 IWCOWSOWLSLUDK-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013068344A JP5929812B2 (ja) | 2012-03-30 | 2013-03-28 | １，２，４−トリアゾロン誘導体を含有する医薬 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012079448 | 2012-03-30 | ||
| JP2012079448 | 2012-03-30 | ||
| JP2013068344A JP5929812B2 (ja) | 2012-03-30 | 2013-03-28 | １，２，４−トリアゾロン誘導体を含有する医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013227299A JP2013227299A (ja) | 2013-11-07 |
| JP2013227299A5 JP2013227299A5 (enrdf_load_stackoverflow) | 2015-02-19 |
| JP5929812B2 true JP5929812B2 (ja) | 2016-06-08 |
Family
ID=49675343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013068344A Active JP5929812B2 (ja) | 2012-03-30 | 2013-03-28 | １，２，４−トリアゾロン誘導体を含有する医薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5929812B2 (enrdf_load_stackoverflow) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103119028B (zh) * | 2010-10-01 | 2016-05-25 | 大正制药株式会社 | 1,2,4-三唑酮衍生物 |
-
2013
- 2013-03-28 JP JP2013068344A patent/JP5929812B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013227299A (ja) | 2013-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5787237B2 (ja) | １，２，４−トリアゾロン誘導体 | |
| JP6770053B2 (ja) | Ｒｏｃｋ阻害剤としてのフタラジノンおよびイソキノリノン | |
| CN109153663B (zh) | 作为rock抑制剂的三唑酮类化合物和四唑酮类化合物 | |
| KR20110050718A (ko) | 치환된 아미노인단 및 그의 유사체, 및 그의 제약 용도 | |
| JPWO2013187466A1 (ja) | 分岐鎖アルキルヘテロ芳香環誘導体 | |
| WO2009009411A1 (en) | Substituted heterocyclic ethers and their use in cns disorders | |
| US20120142685A1 (en) | Organic compounds | |
| JPWO2012036278A1 (ja) | グリシントランスポーター阻害物質 | |
| TW202342464A (zh) | Rna解旋酶dhx9之抑制劑及其用途 | |
| JPWO2013147117A1 (ja) | 縮環アゾール誘導体 | |
| KR20140023331A (ko) | 피라졸로 피리미딘 유도체 | |
| JP4031814B2 (ja) | ピペリジニルカルボニル−ピロリジンおよびメラノコルチンアゴニストとしてのそれらの使用 | |
| JPWO2015012400A1 (ja) | グリシントランスポーター阻害物質 | |
| JP5369721B2 (ja) | ピリドピリミジン−４−オン誘導体 | |
| US7649002B2 (en) | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists | |
| US20130244999A1 (en) | Substituted Heterocyclic Compounds | |
| US20150252022A1 (en) | Retinoic acid receptor-related orphan receptor modulators and uses thereof | |
| JP2015131802A (ja) | 分岐鎖アルキルヘテロ芳香環誘導体を含有する医薬 | |
| JP5929812B2 (ja) | １，２，４−トリアゾロン誘導体を含有する医薬 | |
| HK1182109B (en) | 1,2,4-triazolone derivative | |
| WO2017057717A1 (ja) | 複素芳香環誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141222 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141222 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151104 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151229 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20160104 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160405 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160418 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5929812 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |